A
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Price:
524.4
INR
1.64%
Market Cap:
₹80.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
IN |
|
V
|
Vindhya Telelinks Ltd
NSE:VINDHYATEL
|
IN |
|
MasTec Inc
NYSE:MTZ
|
US |
|
Leadtrend Technology Corp
TWSE:3588
|
TW |
|
R
|
Refinverse Group Inc
TSE:7375
|
JP |
|
M
|
Mukka Proteins Ltd
NSE:MUKKA
|
IN |
|
CD Projekt SA
OTC:OTGLF
|
PL |
|
Bisichi PLC
LSE:BISI
|
UK |
|
S
|
Sovereign Metals Ltd
LSE:SVML
|
AU |
|
Tsukui Staff Corp
TSE:7045
|
JP |
|
Dingdong (Cayman) Ltd
NYSE:DDL
|
CN |
|
A
|
aXichem AB (publ)
STO:AXIC A
|
SE |
|
Fukuoka REIT Corp
TSE:8968
|
JP |
|
A
|
ASBISc Enterprises PLC
WSE:ASB
|
CY |
Income Statement
Earnings Waterfall
Akums Drugs and Pharmaceuticals Ltd
Akums Drugs and Pharmaceuticals Ltd
Income Statement
Akums Drugs and Pharmaceuticals Ltd
Akums Drugs and Pharmaceuticals Ltd
Currency: INR
| Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
41 231
N/A
|
41 075
0%
|
42 567
+4%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(24 193)
|
(24 160)
|
(24 921)
|
|
| Gross Profit |
17 037
N/A
|
16 916
-1%
|
17 646
+4%
|
|
| Operating Income | ||||
| Operating Expenses |
(13 946)
|
(14 121)
|
(14 548)
|
|
| Selling, General & Administrative |
(7 157)
|
(7 249)
|
(7 387)
|
|
| Depreciation & Amortization |
(1 563)
|
(1 593)
|
(1 544)
|
|
| Other Operating Expenses |
(5 226)
|
(5 279)
|
(5 616)
|
|
| Operating Income |
3 091
N/A
|
2 794
-10%
|
3 098
+11%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(447)
|
(561)
|
(747)
|
|
| Non-Reccuring Items |
167
|
130
|
(100)
|
|
| Total Other Income |
723
|
912
|
1 110
|
|
| Pre-Tax Income |
3 534
N/A
|
3 275
-7%
|
3 360
+3%
|
|
| Net Income | ||||
| Tax Provision |
(62)
|
(42)
|
(114)
|
|
| Income from Continuing Operations |
3 473
|
3 233
|
3 247
|
|
| Income to Minority Interest |
(58)
|
(62)
|
(65)
|
|
| Net Income (Common) |
3 415
N/A
|
3 171
-7%
|
3 182
+0%
|
|
| EPS (Diluted) |
22.32
N/A
|
20.67
-7%
|
20.78
+1%
|
|
Switch to:
Switch to:
See Also
Discover More
